Skip to main content
Clinical Trials/NCT05747131
NCT05747131
Not Yet Recruiting
N/A

Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Children: A Multicenter Study to Assess the Acceptability, Feasibility and Efficacy of a Blended Format of the Program in Portugal

University of Coimbra2 sites in 1 country180 target enrollmentSeptember 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Anxiety Disorders
Sponsor
University of Coimbra
Enrollment
180
Locations
2
Primary Endpoint
Change in severity of anxiety symptoms as measured by the Clinician Global Impression - Severity scale (CGC-S).
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The goal of this clinical trial is to test the efficacy of a blended format (i.e., a combination of face-to-face and online sessions into one integrated treatment protocol) of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Children (UP-C) in a sample of children aged between 7 and 12 years with a primary diagnosis of an anxiety disorder or with clinically significant levels of anxiety.

The main questions it aims to answer are:

  • Is the proposed intervention (named Emotion Detectives In-Out) feasible and acceptable among Portuguese children with anxiety disorders and their parents?
  • Is the Emotion Detectives In-Out intervention as effective as an evidence-based intervention for children's anxiety disorders in reducing anxiety symptomatology and changing secondary outcomes?
  • What are the key predictors of adherence to the Emotion Detectives In-Out intervention?
  • What are the key predictors of treatment outcomes?

Participants (children and one parent/legal representative) will:

  • Participate in an initial interview with a clinical psychologist, who will assess if children and parents meet eligibility criteria.
  • Complete an assessment protocol before, during, and after the intervention, as well as three months later.
  • Be randomly assigned to one of the two conditions: experimental (Emotion Detectives In-Out) or active control (Coping Cat).
  • Participate in one of the two psychological interventions. Researchers will compare the experimental and control groups to see if the Emotion Detectives In-Out intervention is equally efficacious as the Coping Cat intervention.

Detailed Description

Childhood emotional disorders, particularly anxiety disorders, are an important public health concern due to their high and increasing prevalence, impact on children's functioning in multiple domains (e.g., family, academic, social), and long-term consequences. However, there is a significant gap between their needs and access to mental healthcare, with most children lacking access to evidence-based treatments (EBT). Several factors can contribute to a lack of adequate mental health care for children, including an insufficient number of trained clinicians, the difficulty of effectively disseminating the multitude of disorder-specific EBTs for emotional disorders to clinicians, and other barriers to face-to-face treatment. An Internet-based intervention can be an effective solution to overcome these difficulties. This project aims to develop and test the efficacy of a blended intervention of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Children (UP-C). The UP-C is a cognitive-behavioral therapy (CBT) that takes a transdiagnostic approach to treating multiple emotional disorders simultaneously by addressing shared mechanisms underlying these disorders and employing a common set of EBT strategies (e.g., exposure, mindfulness). It is a child-friendly extension of the adult UP that delivers the UP core components in an interactive and child-friendly group format with extensive parent involvement. It has 15 weekly sessions for children and 15 weekly sessions for parents with an approximate duration of 90 minutes each. With a blended approach the researchers aim to improve the delivery of UP-C, by retaining the benefits of face-to-face and online therapy, while mitigating their limitations. This new version is expected to reduce costs of the therapy for families and institutions while also increasing compliance, motivation, uptake of treatment principles, and facilitating generalization of the application of core treatment components. The blended version of the UP-C, named "Emotion Detectives In-Out" consists of 15 weekly sessions with the children (9 face-to-face group sessions, 4 online self-guided sessions and 2 videoconference sessions). The groups will consist of about 5 to 7 children. Face-to-face sessions have an expected duration of 90 minutes and will be implemented by clinical psychologists with specific training in the program. The online sessions were developed by the research team and are completely self-guided. These sessions last approximately 45 minutes. Parents will be asked to participate in 2 face-to-face sessions, 4 videoconference sessions and 10 self-guided online sessions.

Registry
clinicaltrials.gov
Start Date
September 2023
End Date
December 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Helena Moreira

Prof.

University of Coimbra

Eligibility Criteria

Inclusion Criteria

  • The child is aged between 7 and 12 years;
  • The child has a primary diagnosis of an anxiety disorder or clinically significant anxiety symptoms;
  • Both the child and the parent are able to speak, read and understand Portuguese;
  • Both the child and the parent have Internet access.

Exclusion Criteria

  • Diagnosis of a psychotic disorder, bipolar disorder, intellectual disability or autism spectrum disorder;
  • Severe current suicidal ideation;
  • The child is not on a stable dose of a psychotropic or other type of medication for at least 1 month prior to T0 assessment;
  • The child has previously received CBT with exposure techniques.

Outcomes

Primary Outcomes

Change in severity of anxiety symptoms as measured by the Clinician Global Impression - Severity scale (CGC-S).

Time Frame: Baseline, within 1 week post-treatment

The Clinician Global Impression - Severity scale is a one-item measure assessing the clinician's perception of the severity of the patient's symptoms, with scores ranging from 1 (not at all ill) to 7 (extremely ill). Higher scores indicate increased symptom severity.

Change in anxiety symptoms as measured by the Revised Children's Anxiety and Depression Scale (RCADS).

Time Frame: Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up]

The Revised Children's Anxiety and Depression Scale is a 47 item self-report questionnaire that measures symptoms of depression and anxiety in children and adolescents aged 8 - 18. It has 6 subscales: separation anxiety disorder, social phobia, generalized anxiety disorder, panic disorder, obsessive compulsive disorder, and low mood (major depressive disorder). It yields a Total Anxiety Scale (the sum of the 5 anxiety subscales) and a Total Anxiety \& Depression Scale (sum of all 6 subscales). The Total Anxiety Scale ranges from 0 to 111, and the Total Anxiety \& Depression scale ranges from 0 to 141, with higher scores indicating increased symptom severity.

Change in anxiety symptoms as measured by the Revised Children's Anxiety and Depression Scale - Parent version (RCADS-P).

Time Frame: Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up

The Revised Child Anxiety and Depression Scale - Parent Version (RCADS-P) is a 47 item parent-reported questionnaire that measures symptoms of depression and anxiety in children and adolescents aged 8 - 18. It has 6 subscales: separation anxiety disorder, social phobia, generalized anxiety disorder, panic disorder, obsessive compulsive disorder, and low mood (major depressive disorder). It yields a Total Anxiety Scale (the sum of the 5 anxiety subscales) and a Total Anxiety \& Depression Scale (sum of all 6 subscales). The Total Anxiety Scale ranges from 0 to 111, and the Total Anxiety \& Depression scale ranges from 0 to 141, with higher scores indicating increased symptom severity.

Change in anxiety symptoms as measured by the Clinician Global Impression - Improvement scale (CGC-I).

Time Frame: within 1 week post-treatment

Higher scores indicate increased symptom worsening.

Secondary Outcomes

  • Change in the interference of anxiety in child's life, as measured by the Child Anxiety Life Interference Scale - Self-Report (CALIS-C)(Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up)
  • Change in children's behavioral avoidance, as measured by the Child Avoidance Measure Parent-Report (CAMP)(Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up)
  • Change in children's positive and negative affect, as measured by the Positive and Negative Affect Schedule for Children - Short Version (PANAS-C-SF)(Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up)
  • Change in the interference of anxiety in child's life, as measured by the Child Anxiety Life Interference Scale - Parent's Report (CALIS-P)(Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up)
  • Change in children's behavioral avoidance, as measured by the Child Avoidance Measure Self-Report (CAMS)(Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up)
  • Change in children's quality of life, as measured by the KIDSCREEN-10 Index (Parent Report)(Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up)
  • Change in parental criticism as measured by the Egna Minnen Beträffande Uppfostran Scale (EMBU-P)(Baseline, within 1 week post-treatment, 3 months follow-up)
  • Change in parental depressive symptoms, as measured by the Patient Health Questionnaire-9 (PHQ-9).(Baseline, within 1 week post-treatment, 3 months follow-up)
  • Change in children's difficulties in emotion expression, as measured by the Emotional Expression Scale for Children (EESC)(Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up)
  • Change in parental overprotection, as measured by the Parental Anxiety and Overprotection Scale (PAOS)(Baseline, within 1 week post-treatment, 3 months follow-up)
  • Change in parental inconsistency, as measured by the Parenting Inconsistency Scale(Baseline, within 1 week post-treatment, 3 months follow-up)
  • Change in children's anxiety sensitivity, as measured by the Children's Anxiety Sensitivity Inventory-Revised (CASI-R).(Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up)
  • Change in children's negative cognitive errors, as measured by the Children's Negative Cognitive Error Questionnaire (CNCEQ)(Baseline, Mid-treatment (week 7), within 1 week post-treatment, 3 months follow-up)
  • Change in parental modeling of intense emotions, as measured by the Parent Emotion Regulation Scale (PERS)(Baseline, within 1 week post-treatment, 3 months follow-up)
  • Change in parental anxiety symptoms, as measured by the General Anxiety Disorder-7 (GAD-7).(Baseline, within 1 week post-treatment, 3 months follow-up)

Study Sites (2)

Loading locations...

Similar Trials